Ocean Bio-Chem, Inc. manufactures, markets, and distributes appearance, performance, and maintenance products for the marine, automotive, power sports, recreational vehicle, home care, and outdoor power equipment markets in the United States and Canada.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$9.74|
|52 Week High||US$8.23|
|52 Week Low||US$18.03|
|1 Month Change||5.07%|
|3 Month Change||-19.70%|
|1 Year Change||-34.23%|
|3 Year Change||138.73%|
|5 Year Change||245.39%|
|Change since IPO||768.20%|
Recent News & Updates
|OBCI||US Household Products||US Market|
Return vs Industry: OBCI underperformed the US Household Products industry which returned 1.7% over the past year.
Return vs Market: OBCI underperformed the US Market which returned 35.3% over the past year.
Stable Share Price: OBCI is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: OBCI's weekly volatility (7%) has been stable over the past year.
About the Company
Ocean Bio-Chem, Inc. manufactures, markets, and distributes appearance, performance, and maintenance products for the marine, automotive, power sports, recreational vehicle, home care, and outdoor power equipment markets in the United States and Canada. The company offers marine products, including polishes, cleaners, protectants, waxes, enzyme fuel treatments, private label products, motor and teak oils, boat washes, vinyl and teak cleaners, bilge and hull cleaners, silicone and polyurethane sealants, polysulfide sealants, gasket materials, lubricants, antifouling additives, and anti-freeze coolants; and brushes, brush handles, tie-downs, and other related accessories. It also manufactures automotive products, such as fuel treatments for gas and diesel engines, motor oils, greases, and related items; anti-freeze and windshield washes; and automotive polishes, cleaners, and other items.
Ocean Bio-Chem Fundamentals Summary
|OBCI fundamental statistics|
Is OBCI overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|OBCI income statement (TTM)|
|Cost of Revenue||US$35.56m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||1.06|
|Net Profit Margin||16.50%|
How did OBCI perform over the long term?See historical performance and comparison
1.2%Current Dividend Yield
Is Ocean Bio-Chem undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: OBCI ($9.74) is trading below our estimate of fair value ($22.75)
Significantly Below Fair Value: OBCI is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: OBCI is good value based on its PE Ratio (9.2x) compared to the US Household Products industry average (22.5x).
PE vs Market: OBCI is good value based on its PE Ratio (9.2x) compared to the US market (17.9x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate OBCI's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: OBCI is good value based on its PB Ratio (2.1x) compared to the US Household Products industry average (4.7x).
How is Ocean Bio-Chem forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Household industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ocean Bio-Chem has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Ocean Bio-Chem performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: OBCI has high quality earnings.
Growing Profit Margin: OBCI's current net profit margins (16.5%) are higher than last year (12.8%).
Past Earnings Growth Analysis
Earnings Trend: OBCI's earnings have grown significantly by 37.3% per year over the past 5 years.
Accelerating Growth: OBCI's earnings growth over the past year (71.6%) exceeds its 5-year average (37.3% per year).
Earnings vs Industry: OBCI earnings growth over the past year (71.6%) exceeded the Household Products industry 11.7%.
Return on Equity
High ROE: OBCI's Return on Equity (22.9%) is considered high.
How is Ocean Bio-Chem's financial position?
Financial Position Analysis
Short Term Liabilities: OBCI's short term assets ($40.1M) exceed its short term liabilities ($6.4M).
Long Term Liabilities: OBCI's short term assets ($40.1M) exceed its long term liabilities ($4.0M).
Debt to Equity History and Analysis
Debt Level: OBCI's debt to equity ratio (8.8%) is considered satisfactory.
Reducing Debt: OBCI's debt to equity ratio has increased from 2.4% to 8.8% over the past 5 years.
Debt Coverage: OBCI's debt is well covered by operating cash flow (186%).
Interest Coverage: OBCI's interest payments on its debt are well covered by EBIT (82.5x coverage).
What is Ocean Bio-Chem current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: OBCI's dividend (1.23%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.33%).
High Dividend: OBCI's dividend (1.23%) is low compared to the top 25% of dividend payers in the US market (3.6%).
Stability and Growth of Payments
Stable Dividend: OBCI has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: OBCI's dividend payments have increased, but the company has only paid a dividend for 4 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (9.4%), OBCI's dividend payments are thoroughly covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Peter Dornau (81 yo)
Mr. Peter G. Dornau co-founded Ocean Bio-Chem Inc. and has been its Chief Executive Officer, President, Chairman and Director since 1973.
CEO Compensation Analysis
Compensation vs Market: Peter's total compensation ($USD318.97K) is below average for companies of similar size in the US market ($USD548.69K).
Compensation vs Earnings: Peter's compensation has been consistent with company performance over the past year.
Experienced Management: OBCI's management team is seasoned and experienced (14.3 years average tenure).
Experienced Board: OBCI's board of directors are seasoned and experienced ( 14.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Ocean Bio-Chem, Inc.'s employee growth, exchange listings and data sources
- Name: Ocean Bio-Chem, Inc.
- Ticker: OBCI
- Exchange: NasdaqCM
- Founded: 1973
- Industry: Household Products
- Sector: Household
- Market Cap: US$92.392m
- Shares outstanding: 9.49m
- Website: https://www.oceanbiochem.com
Number of Employees
- Ocean Bio-Chem, Inc.
- 4041 SW 47th Avenue
- Fort Lauderdale
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/25 22:15|
|End of Day Share Price||2021/09/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.